Common use of Meetings of the Joint Steering Committee Clause in Contracts

Meetings of the Joint Steering Committee. (a) The JSC shall meet every six (6) months, and at such other times as the Parties may agree. The first meeting of the JSC shall be held as soon as reasonably practicable, but in no event later than ninety (90) days following designation of the members of the JSC under Section 3.2(b). Meetings shall be held at such place or places as are mutually agreed or by teleconference or videoconference; provided, however, that there shall be at least one face-to-face meeting per Calendar Year, unless the Parties otherwise agree. (b) Each Party may from time to time invite a reasonable number of participants, in addition to its representatives, to attend JSC meetings, with the consent of the other Party (which shall not be unreasonably withheld); provided, that that if GW intends to have any Third Party (including any consultant) attend such a meeting, such Third Party will be subject to the prior approval of Novartis and must be bound by confidentiality obligations consistent with the terms of this Agreement. (c) Novartis shall appoint one of its representatives on the JSC to act as chairperson of the JSC. The chairperson shall set agendas for JSC meetings, provided that the agendas will include any matter requested by either Party. The chairperson shall be responsible for recording, preparing and, within a reasonable time, issuing draft minutes of each JSC meeting, which draft minutes shall be subject to review and approval by all JSC members.

Meetings of the Joint Steering Committee. (a) The JSC shall meet every six (6) months, on a quarterly basis and at such other times as the Parties may agree. The first meeting of the JSC shall be held as soon as reasonably practicable, but in no event later than ninety (90) days following designation of the members of the JSC under Section 3.2(b)Effective Date. Meetings shall be held at such place or dates and places as are mutually agreed or by teleconference or videoconference; provided, however, that there shall be at least one face-to-face meeting per Calendar Year, unless the Parties otherwise agree. (b) Each Party may from time to time invite a reasonable number of participants, in addition to its representatives, to attend JSC meetingsmeetings in a non-voting capacity, with the consent of the other Party (which shall not be unreasonably withheld); provided, that that if GW either Party intends to have any Third Party (including any consultant) attend such a meeting, such Third Party will be subject to the prior approval of Novartis the other Party and must be bound by confidentiality obligations consistent with the terms of this Agreement. (c) Novartis Each Party shall appoint one (1) of its representatives on the JSC to act as chairperson co-chairpersons of the JSC. The chairperson chairpersons shall set agendas for JSC meetings, provided that the agendas will include any matter requested by either Party. The chairperson chairpersons shall be responsible for recording, preparing and, within a reasonable time, issuing draft minutes of each JSC meeting, which draft minutes shall be subject to review and approval by all JSC membersthe JSC.

Meetings of the Joint Steering Committee. (a) The JSC shall meet every six (6) months, [*] per Calendar Year and at such other times as the Parties may agree. The first meeting of the JSC shall be held as soon as reasonably practicable, but in no event later than ninety (90) days [*] following designation of the members of the JSC under Section 3.2(b)License Effective Date. Meetings shall be held at such place or places as are mutually agreed or by teleconference or videoconference; provided, however, that there shall be at least one face-to-face meeting per Calendar Year, unless the Parties otherwise agree. (b) Each Party may from time to time invite a reasonable number of participants, in addition to its representatives, to attend JSC meetingsmeetings in a non-voting capacity, with the consent of the other Party (which shall not be unreasonably withheld); provided, that that if GW Quark intends to have any Third Party (including any consultant) attend such a meeting, such Third Party will be subject to the prior approval of Novartis and must be bound by confidentiality obligations consistent with the terms of this Agreement. (c) Novartis shall appoint one of its representatives on the JSC to act as chairperson of the JSC. The chairperson shall set agendas for JSC meetings, provided that the agendas will include any matter requested by either Party. The chairperson shall be responsible for recording, preparing and, within a reasonable time, issuing (i) draft minutes of each JSC meeting, which draft minutes shall be subject to review and approval by all JSC members, and (ii) final minutes following such approval.